# The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

> **NCT00250198** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 12 (—)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** STA-5326

## Key facts

- **NCT ID:** NCT00250198
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-03
- **Primary completion:** —
- **Final completion:** 2006-09-05
- **Target enrollment:** 12 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250198, "The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00250198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*